1.Yinon, Y et al. (2010) Cytomegalovirus infection in pregnancy. Journal of Obstetrics and Gynaecology Canada 32, 348–354.
2.Kenneson, A and Cannon, MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Reviews in Medical Virology 17, 253–276.
3.Enders, G et al. (2012) Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996–2010. Medical Microbiology Immunology 201, 303–309.
4.Uysal, A et al. (2012) Cytomegalovirus and rubella seroprevalence in pregnant women in Izmir/Turkey: follow-up and results of pregnancy outcome. Archives of Gynecology and Obstetrics 286, 605–608.
5.Jin, Q et al. (2017) Cytomegalovirus infection among pregnant women in Beijing: seroepidemiological survey and intrauterine transmissions. Journal of Microbiology and Biotechnology 27, 1005–1009.
6.Wang, S et al. (2017) Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China. Medicine (Baltimore) 96, e6007.
7.Schopfer, K et al. (1978) Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy. Archives of Disease in Childhood 53, 536–539.
8.Boppana, SB et al. (1999) Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 104, 55–60.
9.de Vries, JJ et al. (2013) The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model. Reviews in Medical Virology 23, 241–249.
10.Mussi-Pinhata, MM et al. (2009) Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clinical Infectious Diseases 49, 522–528.
11.Boppana, SB et al. (2001) Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. The New England Journal of Medicine 344, 1366–1371.
12.Tanimura, K et al. (2017) Universal screening with use of immunoglobulin G avidity for congenital cytomegalovirus infection. Clinical Infectious Diseases 65, 1652–1658.
13.Cannon, MJ et al. (2011) Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Reviews in Medical Virology 21, 240–255.
14.Yan, XC et al. (2015) Study of human cytomegalovirus replication in body fluids, placental infection, and miscarriage during the first trimester of pregnancy. Journal of Medical Virology 87, 1046–1053.
15.Tanaka, K et al. (2006) Screening for vaginal shedding of cytomegalovirus in healthy pregnant women using real-time PCR: correlation of CMV in the vagina and adverse outcome of pregnancy. Journal of Medical Virology 78, 757–759.
16.Amin, MM et al. (2018) Urinary cytomegalovirus shedding in the United States: The National Health and Nutrition Examination Surveys, 1999–2004. Clinical Infectious Diseases 67, 587–592.
17.Adachi, K et al. (2017) Cytomegalovirus urinary shedding in HIV-infected pregnant women and congenital cytomegalovirus infection. Clinical Infectious Diseases 65, 405–413.
18.Delforge, ML et al. (2017) Presence of cytomegalovirus in urine and blood of pregnant women with primary infection might be associated with fetal infection. Journal of Clinical Virology 90, 14–17.
19.Barbosa, NG et al. (2018) Cytomegalovirus shedding in seropositive pregnant women from a high-seroprevalence population: the Brazilian Cytomegalovirus Hearing and Maternal Secondary Infection Study. Clinical Infectious Diseases 67, 743–750.
20.Pascual, T et al. (2018) Monitoring of oral cytomegalovirus DNA shedding for the prediction of viral DNAemia in allogeneic hematopoietic stem cell transplant recipients. Journal of Medical Virology 90, 1375–1382.
21.Kwon, S et al. (2015) Comparison of quantitation of cytomegalovirus DNA by real-time PCR in whole blood with the cytomegalovirus antigenemia assay. Annals of Laboratory Medicine 35, 99–104.
22.Knox, GE et al. (1979) Comparative prevalence of subclinical cytomegalovirus and herpes simplex virus infections in the genital and urinary tracts of low-income, urban women. Journal of Infectious Diseases 140, 419–422.
23.Stagno, S et al. (1975) Cervical cytomegalovirus excretion in pregnant and nonpregnant women: suppression in early gestation. Journal of Infectious Diseases 131, 522–527.
24.Collier, AC et al. (1995) Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. Journal of Infectious Diseases 171, 33–38.
25.Yang, YS et al. (1995) Cytomegalovirus infection and viral shedding in the genital tract of infertile couples. Journal of Medical Virology 45, 179–182.
26.Shen, CY et al. (1993) Cytomegalovirus excretion in pregnant and nonpregnant women. Journal of Clinical Microbiology 31, 1635–1636.
27.Huang, Y et al. (2018) Cytomegalovirus shedding in healthy seropositive female college students: a 6-month longitudinal study. Journal of Infectious Diseases 217, 1069–1073.
28.Berntsson, M et al. (2013) Frequent detection of cytomegalovirus and Epstein-Barr virus in cervical secretions from healthy young women. Acta Obstetricia et Gynecologica Scandinavica 92, 706–710.
29.Schoenfisch, AL et al. (2011) Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women. Journal of Medical Microbiology 60, 768–774.
30.Revello, MG et al. (2014) Cytomegalovirus DNAemia in pregnant women. Journal of Clinical Virology 61, 590–592.
31.Forman, MS et al. (2017) Cytomegalovirus kinetics following primary infection in healthy women. Journal of Infectious Diseases 215, 1523–1526.
32.Bate, SL et al. (2010) Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004. Clinical Infectious Diseases 50, 1439–1447.
33.Silver, MI et al. (2011) Shedding of Epstein-Barr virus and cytomegalovirus from the genital tract of women in a periurban community in Andhra Pradesh, India. Journal of Clinical Microbiology 49, 2435–2439.
34.Lazzarotto, T et al. (1992) Enzyme-linked immunoadsorbent assay for the detection of cytomegalovirus-IgM: comparison between eight commercial kits, immunofluorescence, and immunoblotting. Journal of Clinical Laboratory Analysis 6, 216–218.
35.Tanimura, K et al. (2017) Prediction of congenital cytomegalovirus infection in high-risk pregnant women. Clinical Infectious Diseases 64, 159–165.
36.Pass, RF et al. (2006) Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. Journal of Clinical Virology 35, 216–220.